Politico January 21, 2025
Ruth Reader, Carmen Paun, Daniel Payne and Erin Schumaker

POLICY PUZZLE

The health tech industry is breathing a little sigh of relief after President Donald Trump revoked former President Joe Biden’s executive order on artificial intelligence Monday.

The repeal isn’t likely to have a big impact. But some in the health industry had been worried about future implications of Biden’s 2023 executive order, which, among other things, required companies with models trained using enormous computing power to regularly send detailed reports to federal regulators, regardless of the company’s size.

“What if, in 20 years, even a small startup has these capabilities? Should every small startup have the same reporting burden?” Punit Soni, CEO of Suki AI, an AI medical scribe company, previously told Ruth.

Many in the industry felt...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Congress / White House, Govt Agencies, Technology
The 3 most promising uses for GenAI in healthcare
OpenAI’s $40 Billion And Circle IPO: AI And Blockchain’s Revolution
The Flawed Assumption Behind AI Agents’ Decision-Making
Q&A: Researcher discusses agentic AI, expected to be the next trend in digital medicine
Generative AI Is A Crisis For Copyright Law

Share This Article